Skip to main content

Table 1 The patient characteristics of the two clear cell renal cell carcinoma clusters

From: Fibrogenesis-driven tumor progression in clear cell renal cell carcinoma: prognostic, therapeutic implications and the dual role of neuropilin-1

Characteristics

Cluster C1 (n = 147)

Cluster C2 (n = 383)

P-value

Age, median (IQR)

62 (53, 69)

61 (52, 70)

0.847

Gender, n (%)

  

0.018

 Male

107 (20.2%)

237 (44.7%)

 

 Female

40 (7.5%)

146 (27.5%)

 

Histologic grade, n (%)

 G1

0 (0%)

14 (2.7%)

 

 G2

44 (8.4%)

184 (35.2%)

 

 G3

57 (10.9%)

149 (28.5%)

 

 G4

44 (8.4%)

30 (5.7%)

 

Histologic grade (integrated), n (%)

  

 < 0.001

 G1 + G2

44 (8.4%)

198 (37.9%)

 

 G3 + G4

101 (19.3%)

179 (34.2%)

 

Pathologic stage, n (%)

 Stage I

49 (9.3%)

217 (41.2%)

 

 Stage II

18 (3.4%)

39 (7.4%)

 

 Stage III

46 (8.7%)

77 (14.6%)

 

 Stage IV

32 (6.1%)

49 (9.3%)

 

Pathologic stage (integrated), n (%)

  

 < 0.001

 Stage I + Stage II

67 (12.7%)

256 (48.6%)

 

 Stage III + Stage IV

78 (14.8%)

126 (23.9%)

 

T stage, n (%)

 T1

51 (9.6%)

221 (41.7%)

 

 T2

20 (3.8%)

49 (9.2%)

 

 T3

68 (12.8%)

111 (20.9%)

 

 T4

8 (1.5%)

2 (0.4%)

 

T stage (integrated), n (%)

  

 < 0.001

 T1 + T2

71 (13.4%)

270 (50.9%)

 

 T3 + T4

76 (14.3%)

113 (21.3%)

 

N stage, n (%)

  

 < 0.001

 N0

66 (25.9%)

174 (68.2%)

 

 N1

12 (4.7%)

3 (1.2%)

 

M stage, n (%)

  

0.033

 M0

114 (22.8%)

308 (61.7%)

 

 M1

30 (6%)

47 (9.4%)

 

OS event, n (%)

  

 < 0.001

 Alive

80 (15.1%)

277 (52.3%)

 

 Dead

67 (12.6%)

106 (20%)

 
  1. IQR interquartile range, OS overall survival